GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CUC Inc (TSE:9158) » Definitions » EBIT

CUC (TSE:9158) EBIT : 円6,694 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is CUC EBIT?

CUC's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was 円1,701 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was 円6,694 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. CUC's annualized ROC % for the quarter that ended in Sep. 2024 was 8.46%. CUC's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 25.23%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. CUC's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 8.69%.


CUC EBIT Historical Data

The historical data trend for CUC's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CUC EBIT Chart

CUC Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
EBIT
- 1,660.00 3,722.00 3,733.00 4,423.00

CUC Quarterly Data
Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 849.00 1,779.00 1,707.00 1,701.00 1,507.00

Competitive Comparison of CUC's EBIT

For the Medical Care Facilities subindustry, CUC's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CUC's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CUC's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where CUC's EV-to-EBIT falls into.



CUC EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円6,694 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CUC  (TSE:9158) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

CUC's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=6824 * ( 1 - 33.81% )/( (0 + 53414)/ 1 )
=4516.8056/53414
=8.46 %

where

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

CUC's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=6804/( ( (0 + max(0, 0)) + (22387 + max(4579, 0)) )/ 1 )
=6804/( ( 0 + 26966 )/ 1 )
=6804/26966
=25.23 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(9617 + 105 + 420) - (3535 + 0 + 2028)
=4579

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

CUC's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=6694/76990.504
=8.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CUC EBIT Related Terms

Thank you for viewing the detailed overview of CUC's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


CUC Business Description

Traded in Other Exchanges
N/A
Address
3-1-1 Shibaura,, 15th floor, msb Tamachi Tamachi Station Tower N, Minato-ku, Tokyo, JPN, 108-0023
CUC Inc is engaged in Management support business for medical institutions, in-home nursing businesses, and hospice businesses. The company supports home-visit clinics where medical professionals visit the homes and facilities of patients who find it difficult to visit hospitals. It operates a home hospice specializing in caring for people with terminal cancer and intractable diseases and home-visit nursing and nursing care offices (visit only within the facility). We provide mental and physical support so users and their families can lead a positive treatment life.

CUC Headlines

No Headlines